Cardiovascular Institute of the South, 3 ( Site 0096) — Lafayette, Louisiana

Cardiovascular Institute of the South, 3 ( Site 0096) is a clinical research site located in Lafayette, Louisiana, United States 70503.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Cardiovascular Institute of the South, 3 ( Site 0096) has participated in 1 clinical trials.

Therapeutic areas: Chronic Heart Failure With Reduced Ejection Fraction.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cardiovascular Institute of the South, 3 ( Site 0096)?

Cardiovascular Institute of the South, 3 ( Site 0096) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cardiovascular Institute of the South, 3 ( Site 0096) conducted?

Cardiovascular Institute of the South, 3 ( Site 0096) has 1 clinical trials on record. Their work covers Chronic Heart Failure With Reduced Ejection Fraction.

Is Cardiovascular Institute of the South, 3 ( Site 0096) accredited by Crixeo Health?

Cardiovascular Institute of the South, 3 ( Site 0096) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cardiovascular Institute of the South, 3 ( Site 0096)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.